site stats

Cardiovasc drugs ther. impact factor

WebApr 6, 2024 · Expert Review of Cardiovascular Therapy. Publish open access in this journal. Medline-indexed journal on therapeutic cardiology, focusing on heart disease, vascular … WebFeb 15, 2024 · Journal Impact Factor: 0.84 ; Average acceptance to publication time (5-7 days) Average article processing time (30-45 days) Less than 5 volumes 30 days 8 - 9 volumes 40 days 10 and more volumes 45 days

Cardiovascular Drugs and Therapy Latest Journal Impact IF 2024-2…

WebMay 27, 2024 · The impact score (IS) 2024 of Therapeutic Advances in Chronic Disease is 4.49, which is computed in 2024 as per its definition.Therapeutic Advances in Chronic Disease IS is increased by a factor of 0.05 and approximate percentage change is 1.13% when compared to preceding year 2024, which shows a rising trend. The impact score … WebApr 4, 2024 · Cardiovascular Drugs and Therapy is a careful and accurate guide for clinicians and researchers to navigate new products and therapies in cardiovascular pharmacology that will remain an essential and timeless resource. ... Impact factor … Volumes and issues. Volume 37 February - April 2024. April 2024, issue 2; February … chase bank in pineville louisiana https://nextgenimages.com

Cardiovascular Drugs and Therapy Impact Factor IF …

WebThere are many factors influencing the treatment adherence of hypertensive patients. The aim of this study was to examine the effect of social support on the treatment adherence in hypertension in China. ... (r=0.568) had greater impact on treatment adherence than that from kinship (r=0.364) and nuclear family (r=0.262). ... Cardiovasc Drugs ... Web13 rows · Cardiovascular Drugs and Therapy Impact Factor, IF, number of article, detailed information ... WebAlso covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. ... Year: Impact Factor (IF) Total Articles: Total Cites: 2024 (2024 update) 2.755-1938: 2024: 3.231: 86: 1772: 2024: 2.284: 58: 1272: ... Cardiovasc Ther Prev. Cardiovascular ... curtains for orange room

Real-world Comparisons of Direct Oral Anticoagulants for Stroke ...

Category:Therapeutic Advances in Chronic Disease - Impact Factor, …

Tags:Cardiovasc drugs ther. impact factor

Cardiovasc drugs ther. impact factor

Hyperhomocysteinemia, vascular function and atherosclerosis: …

Web13 rows · Journal Abbreviation: CARDIOVASC THER Journal ISSN: 1755-5914. ... Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on … WebClinical evaluation and laboratory analyses, including haemoglobin, renal function (creatinine, urea, cystatin-C); coagulation markers (INR, aPTT); inflammation markers (IL …

Cardiovasc drugs ther. impact factor

Did you know?

WebSubstantial evidence shows that elevated plasma Lp(a) level is a heritable, independent, and possibly causal risk factor for ASCVD through its proatherogenic, proinflammatory, … WebMay 27, 2024 · The impact score (IS) 2024 of Therapeutic Advances in Cardiovascular Disease is 3.03, which is computed in 2024 as per its definition.Therapeutic Advances in …

WebCardiovasc Drugs Ther. 2024 Jun;36(3):511-524. doi: 10.1007/s10557-021-07181-3. ... Nevertheless, drugs targeting human epidermal growth factor receptor 2 (HER-2), angiogenesis, and other tyrosine kinases also come with unexpected cardiac side effects, including heart failure, hypertension, arterial thrombosis, and arrhythmias, and have ... WebMar 30, 2024 · Impact Factor: 2.807 / 5-Year Impact Factor: 2.895 . JOURNAL HOMEPAGE. SUBMIT PAPER. Journal of Cardiovascular Pharmacology and …

WebNov 16, 2012 · Heart rate (HR) is a precisely regulated variable, which plays a critical role in health and disease. Elevated resting HR is a significant predictor of all-cause and cardiovascular mortality in the general population and patients with cardiovascular disease (CVD). β-blocking drugs exert negative effects on regional myocardial blood flow and … WebMar 27, 2024 · Even though stimulants activate sympathetic signaling through differing mechanisms, many of the effects are ultimately the same and can include: 1,2. …

WebCirc Cardiovasc Qual Outcomes. 2009;2(6):607–615. 27. Zeller T, Krankenberg H, Steinkamp H, et al. One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther. 2009;16(6):653–662. 28.

WebJun 29, 2024 · Aims and Scope. Cardiovascular Diagnosis and Therapy (Print ISSN: 2223-3652; Online ISSN: 2223-3660; Cardiovasc Diagn Ther; CDT) is an open access, peer … curtains for palladian style windowsWebBackground: Whether four direct oral anticoagulants (DOACs) are superior to warfarin among Asians with non-valvular atrial fibrillation (NVAF) remains unclear in the real-world setting. Methods: We searched PubMed and Medline + Journals@Ovid + EMBASE from September 17, 2009 to May 4, 2024 to perform a systematic review and meta-analysis of … chase bank in phoenix arizonaWebJan 25, 2024 · Hypertriglyceridemia has been identified as a risk factor for cardiovascular disease and acute pancreatitis. To date, there are only few drug classes targeting triglyceride levels such as fibrates and ω-3 fatty acids. These agents are at times insufficient to address very high triglycerides and the residual cardiovascular risk in … chase bank in pittsburg californiaWebMay 5, 2024 · Finally, there is emerging evidence about new translational drugs on the microcirculation (including growth factors and non-coding RNA therapeutics, as well as the targeting of metabolites or metabolic signaling) . Forthcoming trials would better assess coronary microcirculation by cardiac magnetic resonance imaging (cMRI) (33, 34). … curtains for outdoor pavilioncurtains for peaked windowsWebJan 1, 2024 · Cardiovascular Therapeutics is part of a partnership between Wiley and Hindawi and is now fully open access.Cardiovascular Therapeutics will remain a Wiley title but will be published and hosted … curtains for photo studioWebCardiovascular Therapeutics publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of novel cardiovascular … curtains for pergola roof